NCT06774430Recruiting
Digital Strategies to Advance Help-Seeking Aim 1 and 2
Digital Strategies to Advance Help-Seeking in Youth at Clinical High Risk for Developing Psychosis
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
This proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinical High-Risk (CHR) for developing psychosis. Leveraging the Health Action Process Approach (HAPA) model, this study will identify help-seeking subtypes in 25,000 youth who screen positive for psychosis-risk on Mental Health America's national online screening platform, iteratively develop and test theory and data-driven, personalized strategies to advance help-seeking using Micro-Randomized Trials and a Sequential Multiple Assignment Randomized Trial, identify the most accurate CHR screening threshold in an online environment, and link youth, when indicated, to local clinical care via Accelerating Medicines Partnership - Schizophrenia (AMP-SCZ), a NIH funded national network of CHR programs throughout the US. This academic-industry partnership aims to curate one of the largest datasets of youth with CHR, and to develop effective strategies to enhance early help-seeking, in a population where help-seeking is critical and a significant barrier to care.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25000 (estimated)
- First submitted
- 13 Jan 2025
- Start date
- 7 Apr 2025
- Primary completion date
- 31 May 2028
- Lead sponsor
- Columbia University
- Diseases
- Schizophrenia
- NCT number
- NCT06774430
What you commit to
- Study type: Observational
- Planned participants: 25000
- From 7 Apr 2025 to the primary completion date, 31 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Ages 12-29 years
- Living within a 50-mile radius of a US based AMP-SCZ site
- Able to complete the English language PQ-B on MHA's screening platform
Age in the registry: 12 years to 29 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.